PDEX Pro Dex Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: PDEX

Price (delayed)

$71.94

Market cap

$230.45M

P/E Ratio

16.97

Dividend/share

N/A

EPS

$4.24

Enterprise value

$240.35M

?
Relative Growth: Rel. Growth: 97
Relative Strength: Rel. Strength: 92
Relative Valuation: Rel. Valuation: 75
Relative Profitability: Rel. Profitability: 81

Pro-Dex, Inc. specializes in the design, development, and manufacture of autoclavable, battery-powered and electric, multi-function surgical drivers and shavers used primarily in the orthopedic, thoracic, and maxocranial facial markets. We ...

Highlights
Pro Dex's EPS has surged by 55% YoY and by 15% QoQ
PDEX's net income has surged by 52% year-on-year and by 14% since the previous quarter
Pro Dex's debt has increased by 13% YoY but it has decreased by 6% QoQ
PDEX's P/E is 42% above its last 4 quarters average of 12.0 and 7% above its 5-year quarterly average of 15.9
Sector: Healthcare
Industry: Medical Instruments & Supplies
Website: http://www.pro-dex.com
Peers: RVP ALGN DHR TMO

Key stats

What are the main financial stats of PDEX

PDEX stock price

How has the Pro Dex stock price performed over time
Intraday
-0.65%
1 week
0.13%
1 month
9.55%
1 year
112.15%
YTD
86.95%
QTD
22.87%

Financial performance

How have Pro Dex's revenue and profit performed over time
Revenue
$77.55M
Gross profit
$24.34M
Operating income
$12.99M
Net income
$13.66M
Gross margin
31.4%
Net margin
17.6%
PDEX's net income has surged by 52% year-on-year and by 14% since the previous quarter
Pro Dex's net margin has increased by 30% YoY and by 9% QoQ
Pro Dex's gross profit has increased by 25% YoY and by 17% from the previous quarter
PDEX's operating income is up by 22% year-on-year and by 20% since the previous quarter

Price vs fundamentals

How does PDEX's price correlate with its fundamentals

Growth

What is Pro Dex's growth rate over time

Valuation

What is Pro Dex stock price valuation
PDEX P/E details
P/E
16.97
P/B
4.82
P/S
2.99
EV/EBIT
12.77
EV/EBITDA
11.89
EV/Sales
3.1
Pro Dex's EPS has surged by 55% YoY and by 15% QoQ
PDEX's P/E is 42% above its last 4 quarters average of 12.0 and 7% above its 5-year quarterly average of 15.9
PDEX's price to book (P/B) is 62% higher than its 5-year quarterly average of 3.0 and 47% higher than its last 4 quarters average of 3.3
PDEX's equity is up by 30% year-on-year and by 5% since the previous quarter
The stock's price to sales (P/S) is 77% more than its 5-year quarterly average of 1.7 and 51% more than its last 4 quarters average of 2.0
PDEX's revenue is up by 16% YoY and by 3.9% QoQ

Efficiency

How efficient is Pro Dex business performance
Pro Dex's ROIC has increased by 42% YoY and by 11% from the previous quarter
Pro Dex's return on assets has increased by 32% YoY and by 8% QoQ
Pro Dex's return on sales has increased by 25% YoY and by 8% QoQ
The return on equity has increased by 16% year-on-year and by 7% since the previous quarter

Dividends

What is PDEX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for PDEX.

Financial health

How did Pro Dex financials performed over time
The total assets is 177% greater than the total liabilities
The quick ratio is up by 46% year-on-year and by 13% since the previous quarter
Pro Dex's current ratio has increased by 27% YoY and by 12% QoQ
Pro Dex's debt is 62% lower than its equity
PDEX's equity is up by 30% year-on-year and by 5% since the previous quarter
Pro Dex's debt to equity has decreased by 14% YoY and by 12% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.